Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 6 September 2027
- Last conf. stmt
- 23 August 2026
Obg Scientific Division Limited
- Incorporated
- 4 February 2016 (10 years)
- Industry
- Other business support service activities n.e.c. (82990)
- Directors
- Gerald Francis O'Brien
- Owned by
- Obg Pharmaceuticals Ltd
- Accounts type
- Full
- Region
- North West
- Address
- Ayrton HouseCommerce WayLiverpoolL8 7BA
Charges
- Total
- 2
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 2
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 4 February 2016
British
Born June 1976 (50)
O'Brien, Gerald Francis
Director · Appointed 4 February 2016
British
Born January 1949 (77)
Director · Appointed 4 February 2016
British
Born June 1979 (47)
Officer history (3 former)
7 March 2025
7 March 2025
Resigned Bromiley, Mark as Secretary
2 November 2021
2 July 2021
Appointed Bromiley, Mark as Secretary
2 July 2021
Resigned Didlick, Philip as Secretary
4 February 2016
4 February 2016
Appointed O'Brien, Gerald Francis as Director
4 February 2016
4 February 2016
Appointed Didlick, Philip as Secretary
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Obg Pharmaceuticals Ltd
Corporate entity · Notified 12 January 2024
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited Company
Holdings 4
Companies where Obg Scientific Division Limited is registered as a person with significant control
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Former controllers (2)
12 January 2024
Ceased Gerald Francis O'Brien — Has significant influence or control
12 January 2024
Ceased Bridget Christina O'Brien — Has significant influence or control
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Cash
- £6
- Profit Before Tax
- £450,001
- Current Ratio
- 1.0x
- Return on Equity
- 7500017%
Trend
Shareholder Funds
Balance sheet detail
| 2024 | 2023 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fixed Assets | £1,009 | £1,009 | £1,007 | ||
| Current Assets | £260,007 | £6 | £300,006 | ||
| Debtors | £260,001 | £0 | £300,000 | ||
| Cash | £6 | £6 | £6 | £6 | £6 |
| Creditors (< 1 year) | £261,009 | £261,009 | £261,009 | £1,009 | |
| Net Current Assets | (£1,002) | (£261,003) | £38,997 | (£1,003) | (£1,001) |
| Shareholder Funds | £6 | (£259,995) | £40,006 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 5 September 2025 | Confirmation statement with no updates | 23 August 2025 | ||
| 14 August 2025 | Full accounts | 31 December 2024 | ||
| 11 March 2025 | Termination of appointment of a secretary | |||
| 11 March 2025 | Termination of appointment of a director | |||
| 30 September 2024 | Full accounts | 31 December 2023 |
Some other companies at this address
Other companies in this industry
London
Bagshot
Aylesbury
Leicester
Brighton
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →